EX-12.1 4 a16-22161_1ex12d1.htm EX-12.1

Exhibit 12.1

 

CELLDEX THERAPEUTICS, INC.
COMPUTATION OF RATIO OF EARNINGS TO COMBINED FIXED CHARGES

 

 

 

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30,

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

2013

 

2012

 

2011

 

 

 

 

 

(In thousands)

 

Loss from continuing operations before taxes

 

$

(98,064

)

$

(129,541

)

$

(122,430

)

$

(81,442

)

$

(58,077

)

$

(43,399

)

Fixed Charges:

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expensed and amortization of debt discount

 

—

 

—

 

—

 

927

 

1,576

 

1,796

 

Estimate of interest within rental expense(2)

 

817

 

949

 

906

 

883

 

838

 

841

 

Total fixed charges

 

817

 

949

 

906

 

1,810

 

2,414

 

2,637

 

Loss as defined for ratio to fixed charges

 

$

(97,427

)

$

(128,592

)

$

(121,524

)

$

(79,632

)

$

(55,663

)

$

(40,762

)

Ratio of earnings to fixed charges

 

 

(1)

 

(1)

 

(1)

 

(1)

 

(1)

 

(1)

 

(1)                                 Due to our losses from continuing operations for the nine months ended September 30, 2016 and for the years ended December 31, 2015, 2014, 2013, 2012 and 2011 earnings were insufficient to cover fixed charges by $98.1 million, $129.5 million, $122.4 million, $81.4 million, $58.1 million, and $43.3 million, respectively. For this reason, no ratios are provided.

 

(2)                                 Interest component on rentals estimated to be one-third of rentals.